an early innovator in Artificial Intelligence (AI) and leading supplier of Graph Database technology for Neuro-Symbolic ... capabilities for their agentic AI applications. Additionally, a new tabular ...

Candel Therapeutics announced an oral presentation of CAN-2409 data at the ASCO Annual Meeting, focusing on prostate cancer treatment. Candel Therapeutics, Inc. announced the acceptance of an ...

The presentation will focus on results from its ongoing open-label, randomized Phase I/II study EVICTION, including updated efficacy, safety and dose-selection data on the company’s lead γ9δ2 ...

Further, the protocol will involve five stages: identifying the research question, identifying relevant studies, study selection, data charting ... will involve graphical and tabular summaries.